View of Neutrophil-to-lymphocyte ratio predicts long-term survival in early triple-negative breast cancer treated with neoadjuvant chemotherapy

Return to Article Details Neutrophil-to-lymphocyte ratio predicts long-term survival in early triple-negative breast cancer treated with neoadjuvant chemotherapy Download Download PDF